Clinical Research: Phase 1 - Phase 4

A New Era in Dermatology: Study Design, Regulatory Strategies, and Patient Participation, Upcoming Webinar

TORONTO (PRWEB)AUGUST 28, 2020 New treatment options for moderate to severe dermatological diseases and areas of high unmet need are driving a revolution in clinical development of dermatology drugs. But questions remain: What indications should be pursued? How to design a study that targets the right endpoints? And how will environmental constraints affect the research?

This webinar will explore dermatology trials from the vantage point of study design, patient access, data quality, regulatory considerations, and more. Panelists will discuss what’s required to understand the disease burden, patients’ treatment goals, and critical elements in devising effective recruitment and retention strategies.

Panelists will discuss the importance of careful study design in creating a trial that meets regulatory and safety guidelines and selects endpoints that will demonstrate the value of the investigational drug while staying flexible throughout the trial. The webinar will also examine the evolving regulatory environment, emphasizing the importance of early communication with regulators — including what to ask and how.

Join Kristi Miller, Ph.D., Head of Global Regulatory Affairs Strategy, RPI, A Division of Premier Research and Lori Lombardo, Senior Director, Program Delivery, Premier Research in a live webinar on Monday, September 14, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit A New Era in Dermatology: Study Design, Regulatory Strategies, and Patient Participation.